Suchergebnisse - "Parkinson's disease (PD)"

PubPharm (584)

1

Activation and Purification of ß-Glucocerebrosidase by Exploiting its Transporter LIMP-2 - Implications for Novel Treatment Strategies in Gaucher's and Parkinson's Disease

enthalten in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) | 2024

von Dobert, J. | Bub, S. | Mächtel, R. | +11

2

Salivary α-Synuclein as a Candidate Biomarker of Parkinsonism in 22q11.2 Deletion Syndrome

enthalten in: Movement disorders clinical practice | 2024

von Fanella, M. | Cerulli Irelli, E. | Accinni, T. | +6

3

Delayed-onset seizures after subthalamic nucleus deep brain stimulation surgery for Parkinson's disease

enthalten in: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia | 2024

von Wu, B. | Liu, J. | Jiang, L. | +7

4

Spatial neurolipidomics-MALDI mass spectrometry imaging of lipids in brain pathologies

enthalten in: Journal of mass spectrometry : JMS | 2024

von Jha, D. | Blennow, K. | Zetterberg, H. | +2

5

Slow-wave sleep and REM sleep without atonia predict motor progression in Parkinson's disease

enthalten in: Sleep medicine | 2024

von Tao, M. | Meng, L. | Xie, W. | +8

6

A review of machine learning and deep learning algorithms for Parkinson's disease detection using handwriting and voice datasets

enthalten in: Heliyon | 2024

von Islam, M. | Hasan Majumder, M. | Hussein, M. | +2

7

VPS35 and retromer dysfunction in Parkinson's disease

enthalten in: Philosophical transactions of the Royal Society of London. Series B, Biological sciences | 2024

von Rowlands, J. | Moore, D.

8

Inflammation, Autoimmunity and Neurodegenerative Diseases, Therapeutics and Beyond

enthalten in: Current neuropharmacology | 2024

von Garmendia, J. | De Sanctis, C. | Das, V. | +3

9

LRRK2; Communicative Role in the Treatment of Parkinson's Disease and Ulcerative Colitis Overlapping

enthalten in: CNS & neurological disorders drug targets | 2024

von Lashgari, N. | Roudsari, N. | Niknejad, A. | +6

10

Vinpocetine improves dyskinesia in Parkinson's disease rats by reducing oxidative stress and activating the Wnt/β-catenin signaling pathway

enthalten in: Chemical biology & drug design | 2024

von Ji, M. | Niu, S. | Mi, H. | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[59]